ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

KIT signaling in gastrointestinal stromal tumors (GIST)

KIT signaling in gastrointestinal stromal tumors (GIST)
Physiologic KIT activation is triggered by binding of the dimeric KIT ligand (SCF) to the extracellular, ligand-binding domain of the KIT receptor tyrosine kinase. This in turn leads to homodimerization of two KIT molecules, which is accompanied by structural changes in the receptor and activation (autophosphorylation) of the intracellular KIT kinase domain. The phosphorylated tyrosine residues on KIT serve as binding sites for various cell signaling proteins, resulting in the activation of various signaling cascades, such as the PI3K/AKT/mTOR, RAS/RAF/MAPK, and the JAK/STAT pathways. Ultimately, the activated KIT receptor stimulates intracellular signaling pathways controlling cell proliferation, adhesion, apoptosis, survival, and differentiation.
SCF: stem cell factor; PI3K: phosphoinositide 3-kinase; PDK1/2: pyruvate dehydrogenase kinase isoenzymes 1 and 2; GRB2: growth factor receptor-bound protein 2; MEK: mitogen-activated protein kinase kinase; mTOR: mechanistic target of rapamycin; STAT: signal transducer and activator of transcription; MAPK: mitogen-activated protein kinase.
Reproduced with permission from: Mutation Analysis: Kit and PDGFRA. Available at: http://www.gistsupport.org/about-gist/mutation-analysis-kit-and-pdgfra/ (accessed on July 14, 2017). Copyright © GIST Support International. All rights reserved.
Graphic 113954 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟